Asher Bio
We build better immunotherapies
- Headquarters
- San Carlos, California
- Employees
- 1–10
- Website
- asherbio.com
- Total Funding
- $218.2M
- Last Round
- $55.0M Series CApr 2024
- Rounds
- 4
About
Asher Bio is a biotechnology company developing precisely targeted immunotherapies for cancer and other diseases. Our cis-targeting platform aims to enable selective activation of specific immune cell types, addressing the inherent limitations of otherwise pleiotropic immunotherapies that act on multiple cell types. Our approach has the potential to precisely direct different immune mediators against a range of target immune cell-types and create best-in-class immunotherapies in cancer, autoimmune and infectious diseases. Asher Bio is backed by Third Rock Ventures and is located in South San Francisco.
Summary
Asher Bio is a Biotech company based in San Carlos, United States. It has raised $218.2M in total across 4 rounds, most recently a $55.0M Series C round in Apr 2024. Investors include RA Capital Management, Wellington Management Company and Third Rock Ventures.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Apr 2024
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Create Free AccountInvestors
Similar Companies
Biopharmaceutical services company
Specialty pharmaceutical company
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...